Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy (NCT04171440) | Clinical Trial Compass
CompletedNot Applicable
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
United States91 participantsStarted 2020-02-18
Plain-language summary
This is a multi-site prospective, single arm, observational study examining the outcomes of robotic pancreaticoduodenectomy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥18 years old
* Symptomatic benign, premalignant, or resectable malignant periampullary and pancreatic tumor requiring resection
* Fit to undergo elective pancreaticoduodenectomy after evaluation by the surgical and anesthesiology teams
* Able to consent to participate in the study
* Appropriate for robotic approach as determined by participating surgeons
Exclusion Criteria:
* Arterial (superior mesenteric artery, celiac axis, hepatic artery) or venous involvement (superior mesenteric vein, portal vein) which meets the definition of borderline or unresectable tumor
* Pregnancy
* BMI \>40 kg/m2
* Patient requires an additional surgical resection during the index operation (such as hepatectomy or colectomy)
What they're measuring
1
Length of hospital stay
Timeframe: up to 90 days post intervention
Trial details
NCT IDNCT04171440
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins